Shanghai - Delayed Quote CNY

InnoCare Pharma Limited (688428.SS)

Compare
13.39 -0.24 (-1.76%)
At close: 3:00:02 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
780,726.00
738,537.00
625,404.00
1,043,033.00
1,364.00
Cost of Revenue
112,503.00
128,435.00
143,397.00
65,667.00
--
Gross Profit
668,223.00
610,102.00
482,007.00
977,366.00
1,364.00
Operating Expense
1,310,415.00
1,259,815.00
1,213,147.00
1,143,605.00
495,911.00
Operating Income
-642,192.00
-649,713.00
-731,140.00
-166,239.00
-494,547.00
Net Non Operating Interest Income Expense
167,932.00
157,264.00
119,869.00
132,493.00
95,670.00
Pretax Income
-482,945.00
-644,206.00
-893,727.00
-20,121.00
-391,865.00
Tax Provision
1,455.00
1,426.00
--
46,558.00
--
Net Income Common Stockholders
-470,892.00
-631,263.00
-886,593.00
-64,545.00
-391,395.00
Diluted NI Available to Com Stockholders
-470,892.00
-631,263.00
-886,593.00
-64,545.00
-391,395.00
Basic EPS
-0.28
-0.37
-0.60
-0.05
-0.40
Diluted EPS
-0.28
-0.37
-0.60
-0.05
-0.40
Basic Average Shares
1,689,175.50
1,687,470.00
1,479,565.00
1,366,261.00
967,576.00
Diluted Average Shares
1,689,175.50
1,687,470.00
1,479,565.00
1,366,261.00
967,576.00
Total Expenses
1,422,918.00
1,388,250.00
1,356,544.00
1,209,272.00
495,911.00
Net Income from Continuing & Discontinued Operation
-470,892.00
-631,263.00
-886,593.00
-64,545.00
-391,395.00
Normalized Income
-456,202.50
-622,987.50
-893,050.00
-69,570.75
-391,395.00
Interest Income
193,121.00
192,333.00
136,914.00
135,135.00
96,809.00
Interest Expense
25,151.00
35,031.00
17,045.00
2,642.00
1,139.00
Net Interest Income
167,932.00
157,264.00
119,869.00
132,493.00
95,670.00
EBIT
-457,794.00
-609,175.00
-876,682.00
-17,479.00
-390,726.00
EBITDA
-359,498.00
-516,554.00
-808,279.00
16,232.00
-379,274.00
Reconciled Cost of Revenue
112,503.00
128,435.00
143,397.00
65,667.00
--
Reconciled Depreciation
98,296.00
92,621.00
68,403.00
33,711.00
11,452.00
Net Income from Continuing Operation Net Minority Interest
-470,892.00
-631,263.00
-886,593.00
-64,545.00
-391,395.00
Total Unusual Items Excluding Goodwill
-19,586.00
-11,034.00
6,457.00
6,701.00
--
Total Unusual Items
-19,586.00
-11,034.00
6,457.00
6,701.00
--
Normalized EBITDA
-339,912.00
-505,520.00
-814,736.00
9,531.00
-379,274.00
Tax Rate for Calcs
0.00
0.00
--
0.00
--
Tax Effect of Unusual Items
-4,896.50
-2,758.50
--
1,675.25
--
12/31/2020 - 9/21/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

50BA.SG Bicycle Therapeutics PLC
13.80
+5.34%
 
6996.HK Antengene Corporation Limited
0.610
-4.69%
 
1541.HK IMMUNEONCO-B
6.140
+1.99%
 
2171.HK CARsgen Therapeutics Holdings Limited
9.650
-0.31%
 
CASI CASI Pharmaceuticals, Inc.
3.1100
+2.98%
 
ERNA Eterna Therapeutics Inc.
0.2890
-0.28%
 
IMAB I-Mab
1.0000
0.00%
 
IPSC Century Therapeutics, Inc.
1.2200
-2.40%
 
APLM Apollomics, Inc.
8.34
+7.76%
 
LEGN Legend Biotech Corporation
35.12
-1.04%